The Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1010 Johnson St, Tallulah, LA 71282 Phone: 318-574-2369 Fax: 318-574-1111 |
News Archive
A new and important genetic discovery, which sheds light on how prostate cancers develop and spread, has been made by an international research team led by scientists at The University of Nottingham.
Weighing is critical to most manufacturing processes. However, many manufacturers overlook the importance of regular maintenance of their weighing assets, leading to equipment failure and downtime. A new METTLER TOLEDO article details 11 reasons why proactive, rather than reactive, maintenance can help manufacturers protect their important profit margins.
T2D Lifestyle, a national survey by Health Union of more than 400 individuals living with type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
› Verified 2 days ago